Pubblicazioni

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 Ã 2 factorial, randomised phase 3 trial

2015 - THE LANCET

Del Mastro, L.; De Placido, S.; Bruzzi, P.; De Laurentiis, M.; Boni, C.; Cavazzini, G.; Durando, A.; Turletti, A.; Nistico, C.; Valle, E.; Garrone, O.; Puglisi, F.; Montemurro, F.; Barni, S.; Ardizzoni, A.; Gamucci, T.; Colantuoni, G.; Giuliano, M.; Gravina, A.; Papaldo, P.; Bighin, C.; Bisagni, G.; Forestieri, V.; Cognetti, F.

Pubblicazioni

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 Ã 2 factorial, randomised phase 3 trial

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 Ã 2 factorial, randomised phase 3 trial